Summary:
Click image to enlargeWe are now enrolling adults and childen for a clinical trial evaluating the effectiveness of an at-home diagnostic device for respiratory syncytial virus (RSV).The visit will take approximately 30 minutes and study participants will undergo nasal swab testing.
Qualified Participants Must:
A known current diagnosis of respiratory syncytial virus (RSV)
Must not be a healthcare provider (doctor, nurse, dentist, etc.)
Qualified Participants May Receive:
$200 compensation for time and effort